| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Classified under Pharmaceuticals (Health Care sector), BCRX's insider flows are most useful compared with peers in the same group.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Dir | 1.34M | $13.00M | - | |
| CFO | 268.7K | - | - | |
| Other | 205.2K | - | - | |
| Dir | 109.6K | $1.06M | - | |
| Dir | 80.6K | - | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 24, 2024 | McKee Amy E | Director | Sell | 8,600 | $6.32 | $54,352.00 | -23.6% | +24.2% | +58.4% | |
| Jun 17, 2024 | Sanders MacHelle45 | Director | Sell | 4,689 | $6.00 | $28,134.00 | -14.5% | +26.8% | +59.8% | |
| Jun 14, 2024 | Heggie Theresa | Director | Sell | 6,698 | $6.11 | $40,924.78 | -11.2% | +25.6% | +68.1% | |
| May 30, 2024 | Levin Alan G | Director | Buy | 7,861 | $6.36 | $49,995.96 | +21.2% | +30.1% | +63.6% | |
| May 24, 2024 | Aselage Steve80 | Director | Buy | 2,500 | $6.40 | $16,000.00 | New | +29.4% | +72.8% | |
| May 20, 2024 | Hutson Nancy J58 | Director | Buy | 5,000 | $6.38 | $31,900.00 | +6.1% | +28.2% | +68.5% | |
| May 20, 2024 | Milano Vincent | Director | Buy | 15,000 | $6.25 | $93,750.00 | +28.8% | +28.2% | +68.5% | |
| May 14, 2024 | Doyle Anthony70 | Chief Financial Officer | Buy | 36,300 | $5.57 | $202,191.00 | +15.8% | +44.2% | +83.8% | |
| May 14, 2024 | Thackray Helen M.78 | Chief R&D Officer | Buy | 30,000 | $5.86 | $175,800.00 | +12.4% | +44.2% | +83.8% | |
| May 13, 2024 | Barnes Alane P70 | Chief Legal Officer | Buy | 5,000 | $5.53 | $27,650.00 | +1.7% | +37.3% | +78.7% |